Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F MARTELLI

Showing results (371-380 of 422) with videos related to

Pageof 43
Sort By:
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Haematologica|June 1, 1982
Long-term survival in adult acute leukemia. A multicenter study of 56 patientsS Tura, M Gobbi, M Cavo, et al.
Clinical Epigenetics|March 29, 2023
Distinguishable DNA methylation defines a cardiac-specific epigenetic clockA Mongelli, S Panunzi, M Nesta, et al.
Blood|February 5, 2011
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationMauro Di Ianni, Franca Falzetti, Alessandra Carotti, et al.
Blood|February 4, 2006
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AMLBrunangelo Falini, Niccolò Bolli, Jing Shan, et al.
Haematologica|July 8, 2008
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)Arcangelo Liso, Filippo Castiglione, Antonio Cappuccio, et al.
The New England Journal of Medicine|January 22, 2005
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotypeBrunangelo Falini, Cristina Mecucci, Enrico Tiacci, et al.
Bone Marrow Transplantation|February 11, 2023
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemiaM S Massei, I Capolsini, E Mastrodicasa, et al.
Blood|July 17, 2010
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceMaria Paola Martelli, Valentina Pettirossi, Christian Thiede, et al.
Leukemia|December 13, 2005
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AMLB Falini, B Bigerna, A Pucciarini, et al.
Pageof 43

Showing results (371-380 of 422) with videos related to

Sort By:
Pageof 43
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Haematologica|June 1, 1982
Long-term survival in adult acute leukemia. A multicenter study of 56 patientsS Tura, M Gobbi, M Cavo, et al.
Clinical Epigenetics|March 29, 2023
Distinguishable DNA methylation defines a cardiac-specific epigenetic clockA Mongelli, S Panunzi, M Nesta, et al.
Blood|February 5, 2011
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationMauro Di Ianni, Franca Falzetti, Alessandra Carotti, et al.
Blood|February 4, 2006
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AMLBrunangelo Falini, Niccolò Bolli, Jing Shan, et al.
Haematologica|July 8, 2008
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)Arcangelo Liso, Filippo Castiglione, Antonio Cappuccio, et al.
The New England Journal of Medicine|January 22, 2005
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotypeBrunangelo Falini, Cristina Mecucci, Enrico Tiacci, et al.
Bone Marrow Transplantation|February 11, 2023
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemiaM S Massei, I Capolsini, E Mastrodicasa, et al.
Blood|July 17, 2010
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceMaria Paola Martelli, Valentina Pettirossi, Christian Thiede, et al.
Leukemia|December 13, 2005
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AMLB Falini, B Bigerna, A Pucciarini, et al.
Pageof 43